Related Experiment Videos
Hairy cell leukemia: treatment prospects
1Repatriation General Hospital, Daws Road, Daw Park, South Australia 5041. prabha.seshadri@rgh.sa.gov.au
Expert Review of Anticancer Therapy
|July 13, 2002
Abstract:
The recent advances in the management of hairy cell leukemia, a chronic and indolent B-cell lymphoproliferative disorder are reviewed. The introduction of alpha-interferon, purine analogs and recombinant monoclonal antibodies/immunotoxins has dramatically improved the outcome in a disease that once had a dismal prognosis. The underlying genetic defect remains unknown.